Ibuprofen Tablet, Coated
NDC Package 57344-212-05
Package Information
Ibuprofen tablets is ■ do not take more than directed■ the smallest effective dose should be used■ adults and children 12 years and older: ■ take 1 caplet every 4 to 6 hours while symptoms persist ■ if pain or fever does not respond to 1 caplet, 2 caplets may be used ■ do not exceed 6 caplets in 24 hours, unless directed by a doctor■ children under 12 years: ask a doctor. This formulation utilizes a tablet, coated delivery system. Marketed by Aaa Pharmaceutical, Inc., this product is identified by NDC 57344-212 and is authorized under FDA application ANDA202312.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 57344 - Aaa Pharmaceutical, Inc.
- 57344-212 - Ibuprofen
- 57344-212-05 - 500 TABLET, COATED in 1 PACKAGE
- 57344-212 - Ibuprofen
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (57344-212). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 57344-212-05 identifies a specific commercial package of 500 tablet, coated in 1 package of Ibuprofen, a human over the counter drug labeled by Aaa Pharmaceutical, Inc.. This tablet, coated is formulated for oral use and contains ibuprofen as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Aaa Pharmaceutical, Inc. on February 16, 2026. The current certification is valid through December 31, 2027.
How is this Aaa Pharmaceutical, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 57344021205. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.